Trade Desk, Inc. is a technology company in the United States and internationally. The company is headquartered in Ventura, California.
| Revenue (TTM) | $2.99B |
| Gross Profit (TTM) | $2.30B |
| EBITDA | $697.98M |
| Operating Margin | 14.20% |
| Return on Equity | 15.40% |
| Return on Assets | 6.25% |
| Revenue/Share (TTM) | $6.26 |
| Book Value | $5.48 |
| Price-to-Book | 2.33 |
| Price-to-Sales (TTM) | 1.99 |
| EV/Revenue | 1.653 |
| EV/EBITDA | 6.93 |
| Quarterly Earnings Growth (YoY) | -23.60% |
| Quarterly Revenue Growth (YoY) | 3.00% |
| Shares Outstanding | $429.69M |
| Float | $416.52M |
| % Insiders | 2.60% |
| % Institutions | 89.06% |
Volatility is currently contracting
Buyers are stepping back into AppLovin (NASDAQ:APP | APP Price Prediction) stock. The move comes after a sharp slide, while ad tech peers The Trade Desk (NASDAQ:TTD) and Digital Turbine (NASDAQ:APPS) are trailing well behind the rebound.
The Trade Desk (TTD) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
The Trade Desk expands healthcare advertising with OptimizeRx, adding authenticated HCP inventory across 400+ EHR and e-prescribing systems.
AppLovin (NASDAQ:APP | APP Price Prediction) stock is down 5% in Wednesday morning trading to $310.70 after Edgewater Research warned that the advertising technology company's market-share growth appears to have stalled. Magnite (NASDAQ:MGNI) stock is down 1.5% to $24.
Index-removal flows are still pressuring The Trade Desk (NASDAQ:TTD | TTD Price Prediction) on Tuesday morning, and its ad-tech peers are moving with it rather than against it.
The Trade Desk (TTD) closed the most recent trading day at $14.27, moving 1.55% from the previous trading session.
Ad tech's supply-side names are running higher Thursday morning after the unsealed remedies opinion in the Justice Department's antitrust case against Alphabet‘s (NASDAQ:GOOGL | GOOGL Price Prediction) Google.
AMZN's ad revenues jump 26% in Q2 as TTD's growth slows to 3%, sharpening the contrast amid rising CTV and retail media momentum.
TTD is expanding healthcare advertising with Veeva Crossix and IQVIA integrations, giving pharma advertisers more granular measurement and media optimization.
TTD expands Audience Unlimited, using AI and simpler data pricing to boost advertiser efficiency and support more durable growth.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on TTD and any ticker you trade — then tracks every position and per-strategy win rate.
